September

New Emergency Department Transition Unit (EDTU) Opened Sept. 1
The 36-bed EDTU, which was previously used for clinic space, was renovated during the past two years to help handle the increasing volume in the very busy Emergency Department
UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells
The UNC School of Medicine lab of Camille Ehre, PhD, generated high-powered microscopic images showing startlingly high SARS-CoV-2 viral loads on human respiratory surfaces, ready to spread infection in infected individuals and transmit infection to others.
UNC Ramps Up Convalescent Plasma Clinical Trial to Fight COVID-19
On the heels of FDA authorization of convalescent plasma as a treatment for COVID-19, researchers at UNC are conducting a clinical trial to determine the safety and efficacy of plasma that includes a higher amount of neutralizing antibodies against SARS-CoV-2.
Chatham Hospital to Open New Maternity Center, Begin Delivering Babies
Goals are to improve health care and outcomes, enable new mothers to stay closer to home
UNC Medical Center and UNC REX Recognized as LGBTQ Healthcare Equality Leaders
Hospitals named to 2020 list for equitable treatment of patients, visitors and employees
Researchers Reveal Safeguarding of a Key DNA Sensor in the Innate Immune System
Led by Qi Zhang, PhD, and Robert McGinty, MD, PhD, UNC-Chapel Hill scientists used cryo-electron microscopy technology to produce the first-ever high-resolution structure of the protein cGAS bound to the DNA packaging unit inside human cell nuclei, revealing how cGAS responds to foreign or damaged DNA, but not the body’s healthy DNA.
Ramsden, Gupta awarded 5-year, $8.8 million grant to study enzyme with important implications for breast and ovarian cancers
The National Cancer Institute has awarded a team led by UNC Lineberger’s Dale Ramsden, PhD, professor in the UNC School of Medicine Department of Biochemistry and Biophysics, a five-year, $8.8 million program project grant to study an enzyme called DNA polymerase theta.
A Scientific First: How Psychedelics Bind to Key Brain Cell Receptor
This work, published in Cell and led by the UNC-Chapel Hill lab of Bryan L. Roth, MD, PhD, sets the stage for the discovery of new kinds of antidepressants, anti-anxiety drugs, and treatments for substance use disorders.
Share This: